Cargando…
SPIRONOLACTONE FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY: A Randomized Controlled Crossover Study
To evaluate the effect of spironolactone, a mineralocorticoid receptor antagonist, for nonresolving central serous chorioretinopathy. METHODS: This is a prospective, randomized, double-blinded, placebo-controlled crossover study. Sixteen eyes of 16 patients with central serous chorioretinopathy and...
Autores principales: | Bousquet, Elodie, Beydoun, Talal, Rothschild, Pierre-Raphaël, Bergin, Ciara, Zhao, Min, Batista, Rui, Brandely, Marie-Laure, Couraud, Benedicte, Farman, Nicolette, Gaudric, Alain, Chast, François, Behar-Cohen, Francine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Retina
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697359/ https://www.ncbi.nlm.nih.gov/pubmed/26017871 http://dx.doi.org/10.1097/IAE.0000000000000614 |
Ejemplares similares
-
Oral Mineralocorticoid-Receptor Antagonists: Real-Life Experience in Clinical Subtypes of Nonresolving Central Serous Chorioretinopathy With Chronic Epitheliopathy
por: Daruich, Alejandra, et al.
Publicado: (2016) -
Subthreshold micropulse yellow laser treatment for nonresolving central serous chorioretinopathy
por: Abd Elhamid, Ahmed Hosni
Publicado: (2015) -
Therapeutic Efficacy of Spironolactone for Central Serous Chorioretinopathy
por: Han, Jae Yong, et al.
Publicado: (2022) -
Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case
por: Kapoor, Kapil G., et al.
Publicado: (2017) -
Visual and Anatomical Outcomes of Spironolactone Therapy in Patients with Chronic Central Serous Chorioretinopathy
por: Falavarjani, Khalil Ghasemi, et al.
Publicado: (2017)